Reuters logo
BRIEF-ProQR announces clearance of IND application to start QR-110 clinical trial
April 27, 2017 / 11:22 AM / 7 months ago

BRIEF-ProQR announces clearance of IND application to start QR-110 clinical trial

April 27 (Reuters) - ProQR Therapeutics NV:

* ProQR Therapeutics NV - top-line trial results are expected in 2018 from trial

* ProQR Therapeutics NV - ProQR can now start clinical development of qr-110 in leber’s congenital amaurosis type 10 (LCA 10) patients

* Proqr announces clearance of IND application to start clinical trial for qr-110 in leber’s congenital amaurosis type 10 patients Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below